Georg Kreuzbauer
Rotkreuz, ZG, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Cumulative review of cardiac failure with acalabrutinib in the treatment of chronic lymphocytic leukemia using data from clinical trials and postmarketing experience.
Journal: HemaSphere
Published: November 05, 2024
Real-world use of blinatumomab in adult patients with B-cell acute lymphoblastic leukemia in clinical practice: results from the NEUF study.
Journal: Blood cancer journal
Published: August 05, 2022
Pediatric patients with acute lymphoblastic leukemia treated with blinatumomab in a real-world setting: Results from the NEUF study.
Journal: Pediatric blood & cancer
Published: August 11, 2021
Assessment of Self-Administration of Romiplostim in Patients with Immune Thrombocytopenic Purpura after Receipt of Home Administration Training Materials: a Cross-Sectional Study.
Journal: Drug safety
Published: September 21, 2018
A systematic literature review and meta-analysis of minimal residual disease as a prognostic indicator in adult B-cell acute lymphoblastic leukemia.
Journal: Haematologica
Published: July 02, 2018
A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
Journal: European journal of haematology
Published: August 24, 2016
Romiplostim Treatment in Adults with Immune Thrombocytopenia of Varying Duration and Severity.
Journal: Acta haematologica
Published: October 27, 2014
Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider.
Journal: European journal of haematology
Published: July 09, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026